Adult Acute Erythroid Leukemia (M6)
5 clinical trials · Condition
◉ Watch Adult Acute Erythroid Leukemia (M6)
| Record | Firm | Date |
|---|---|---|
| CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT02019069) | Rondeep Brar | 2014-02-03 |
| Vorinostat in Treating Patients With Acute Myeloid Leukemia (NCT00305773) | National Cancer Institute (NCI) | 2006-01-01 |
| Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00101296) | National Cancer Institute (NCI) | 2004-10-01 |
| Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT00027872) | National Cancer Institute (NCI) | 2001-10-01 |
| Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia (NCT00006363) | National Cancer Institute (NCI) | 2000-11-01 |
Track Adult Acute Erythroid Leukemia (M6) automatically
Every clearance here is in the API, with alerts when new ones post.